TTK Healthcare Limited (TTKHLTCARE.NS)
INR 1234.9
(-6.27%)
INR 1234.9
(-6.27%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 7.98 Million INR | -34.26% |
| 2022 | 12.14 Million INR | -9.22% |
| 2021 | 13.38 Million INR | 15.6% |
| 2020 | 11.57 Million INR | -7.91% |
| 2019 | 12.57 Million INR | 276.49% |
| 2018 | 3.33 Million INR | -49.36% |
| 2017 | 6.59 Million INR | -24.09% |
| 2016 | 8.68 Million INR | -18.14% |
| 2015 | 10.6 Million INR | -93.36% |
| 2014 | 159.83 Million INR | 0.74% |
| 2013 | 158.66 Million INR | 2646.9% |
| 2012 | 5.77 Million INR | 21.89% |
| 2011 | 4.73 Million INR | -96.18% |
| 2010 | 124.08 Million INR | -13.1% |
| 2009 | 142.79 Million INR | -5.8% |
| 2008 | 151.58 Million INR | 14.56% |
| 2007 | 132.31 Million INR | -3.78% |
| 2006 | 137.5 Million INR | 1.44% |
| 2005 | 135.55 Million INR | -33.56% |
| 2004 | 204.02 Million INR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | - INR | 0.0% |
| 2024 Q2 | - INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q2 | 9.24 Million INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 FY | 7.98 Million INR | -34.26% |
| 2023 Q4 | 7.98 Million INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 15.44 Million INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 FY | 12.14 Million INR | -9.22% |
| 2022 Q4 | 12.14 Million INR | 0.0% |
| 2021 FY | 13.38 Million INR | 15.6% |
| 2021 Q4 | 13.38 Million INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q2 | 13.74 Million INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2020 Q2 | 11.36 Million INR | 0.0% |
| 2020 Q1 | - INR | -100.0% |
| 2020 FY | 11.57 Million INR | -7.91% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q4 | 11.57 Million INR | 0.0% |
| 2019 Q4 | 12.57 Million INR | 0.0% |
| 2019 FY | 12.57 Million INR | 276.49% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q2 | 6.33 Million INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2018 Q2 | 4.8 Million INR | 0.0% |
| 2018 FY | 3.33 Million INR | -49.36% |
| 2018 Q1 | - INR | -100.0% |
| 2018 Q4 | 3.33 Million INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2017 Q4 | 6.59 Million INR | 0.0% |
| 2017 Q3 | - INR | -100.0% |
| 2017 Q2 | 7.61 Million INR | 0.0% |
| 2017 Q1 | - INR | -100.0% |
| 2017 FY | 6.59 Million INR | -24.09% |
| 2016 Q1 | - INR | -100.0% |
| 2016 FY | 8.68 Million INR | -18.14% |
| 2016 Q4 | 8.68 Million INR | 0.0% |
| 2016 Q3 | - INR | -100.0% |
| 2016 Q2 | 1089.59 Billion INR | 0.0% |
| 2015 FY | 10.6 Million INR | -93.36% |
| 2015 Q1 | - INR | -100.0% |
| 2015 Q4 | 10.6 Million INR | 0.0% |
| 2015 Q3 | - INR | -100.0% |
| 2015 Q2 | 158.41 Million INR | 0.0% |
| 2014 Q2 | 190.99 Million INR | 0.0% |
| 2014 Q3 | - INR | -100.0% |
| 2014 Q1 | - INR | -100.0% |
| 2014 FY | 159.83 Million INR | 0.74% |
| 2014 Q4 | 159.83 Million INR | 0.0% |
| 2013 Q2 | 9.07 Million INR | 0.0% |
| 2013 FY | 158.66 Million INR | 2646.9% |
| 2013 Q1 | - INR | -100.0% |
| 2013 Q4 | 158.66 Million INR | 0.0% |
| 2013 Q3 | - INR | -100.0% |
| 2012 FY | 5.77 Million INR | 21.89% |
| 2012 Q4 | 5.77 Million INR | 0.0% |
| 2011 FY | 4.73 Million INR | -96.18% |
| 2011 Q4 | 4.73 Million INR | 0.0% |
| 2010 FY | 124.08 Million INR | -13.1% |
| 2009 FY | 142.79 Million INR | -5.8% |
| 2008 FY | 151.58 Million INR | 14.56% |
| 2007 FY | 132.31 Million INR | -3.78% |
| 2006 FY | 137.5 Million INR | 1.44% |
| 2005 FY | 135.55 Million INR | -33.56% |
| 2004 FY | 204.02 Million INR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Abbott India Limited | 367.6 Million INR | 97.827% |
| Cipla Limited | 2.25 Billion INR | 99.646% |
| Gland Pharma Limited | 1.06 Billion INR | 99.25% |
| GlaxoSmithKline Pharmaceuticals Limited | 64.69 Million INR | 87.654% |
| Kopran Limited | 166.02 Million INR | 95.189% |
| Marksans Pharma Limited | 1.9 Billion INR | 99.58% |
| NGL Fine-Chem Limited | 7.44 Million INR | -7.237% |
| Pfizer Limited | 543.5 Million INR | 98.53% |
| Sanofi India Limited | 139 Million INR | 94.254% |
| SMS Pharmaceuticals Limited | 1.22 Billion INR | 99.346% |